Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man

AimsSmall conductance Ca2+-activated K+ channels (SK channels, KCa2) are a new target for treatment of atrial fibrillation (AF). AP30663 is a small molecule inhibitor of KCa2 channels that is currently in clinical development for treatment of AF. The aim of this study is to present the electrophysio...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Bo Hjorth Bentzen, Sofia Hammami Bomholtz, Rafel Simó-Vicens, Lasse Folkersen, Lea Abildgaard, Tobias Speerschneider, Kalai Mangai Muthukumarasamy, Nils Edvardsson, Ulrik S. Sørensen, Morten Grunnet, Jonas Goldin Diness
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2020-05-01
叢編:Frontiers in Pharmacology
主題:
atrial fibrillation
ion channels
anti-arrhythmic drugs
SK channels
KCa2
在線閱讀:https://www.frontiersin.org/article/10.3389/fphar.2020.00610/full
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍